Krajci: Russian Sputnik Could Be Administered As Part of Clinical Testing

23. februára 2021 21:43
Bratislava, February 23 (TASR) - If the Russian Sputnik V vaccine won't be registered by the EU or the relevant Slovak authority, it could still be administered to applicants in Slovakia as part of the third phase of its clinical trial, Health Minister Marek Krajci (OLaNO) conceded on Tuesday. Krajci noted that he had discussed inoculation with Sputnik V also with scientists and members of the expert consilium. "We decided that if we manage to acquire Sputnik, we would administer it only to those who ask for it and as part of the third phase of the clinical trial, hence it would be in compliance with the European directives and norms," he said. Slovakia could also acquire at least 100,000 vaccine doses from fellow EU member states, which it would then return back in April. A total of 12 out of 14 Slovak MEPs asked European Commission President Ursula von der Leyen to hasten the supplies of vaccines for Slovakia. Slovakia has administered 280,503 first doses and 101,929 second doses of vaccines thus far, with about 7 percent of the population vaccinated. "We're hovering at upper-level rankings in comparison to the EU, but it's no race in principle, as all European countries are saddled with the shortage of vaccines," said the minister. mf/mcs
Všetko o agentúre
Spravodajský servis
Mobilné aplikácie
PR servis OTS
Archív a databázy
Zóna verejného záujmu